Articles tagged with Cardiology
A study published in JAMA found that fractional flow reserve-guided complete revascularization during index procedure resulted in a significant reduction in composite of all-cause death, nonfatal myocardial infarction, any revascularization, and stroke at 1 year. Reduced repeat revascularization was the main driver of this benefit.
Studies show semaglutide and tirzepatide significantly reduce the risk of hospitalization for heart failure or all-cause mortality. These medications offer a promising treatment option for patients with cardiometabolic heart failure with preserved ejection fraction.
Women's participation in cardiovascular trials remained low during this period, limiting generalizability of trial outcomes and perpetuating inequities in care. The study highlights persistent challenges in representation, emphasizing the need for increased female inclusion.
Discontinuing oral anticoagulant therapy after catheter ablation for atrial fibrillation reduces the risk of stroke, systemic embolism, and major bleeding compared to continued direct oral anticoagulant therapy. The study found that long-term discontinuation of anticoagulation therapy resulted in a lower composite outcome of these events.
A recent analysis of the DANFLU-2 trial found that high-dose inactivated influenza vaccine was associated with a lower risk of incident myocarditis or pericarditis compared to standard-dose vaccine. The study suggests no dose-response association and causal link between vaccination and cardiac events.
A new study published in JAMA Cardiology found that microaxial flow pump treatment significantly improves survival rates in patients with infarct-related cardiogenic shock. The study revealed that early systolic blood pressure levels can help identify patients most likely to benefit from this life-saving treatment.
A new study found that high-dose influenza vaccines significantly reduce the incidence of cardiorespiratory hospitalizations in older adults. The results show a lower risk of heart failure hospitalizations among those who received the high-dose vaccine, indicating potential benefits for this population.
A meta-analysis of 8 clinical trials found TAVI to be an effective alternative for patients at low-to-intermediate risk with severe symptomatic aortic stenosis, reducing the 1-year incidence of all-cause death or stroke. Long-term follow-up is needed to evaluate the sustainability of these findings.
A bivalent RSV prefusion F protein-based vaccine was found to lower all-cause cardiorespiratory hospitalization rates in adults aged 60 or older. Although the effect on all-cause cardiovascular hospitalization was not statistically significant, the study suggests potential downstream cardiorespiratory benefits of RSV immunization.
A recent study found that clonal hematopoiesis of indeterminate potential (CHIP) significantly increases the risk of developing new-onset myocarditis and pericarditis among middle-aged adults. Targeting CHIP and its downstream pathways may offer a promising approach for preventing or treating these conditions.
The study analyzed cross-sectional surveys in 22 African countries to identify key factors affecting cardiovascular health. It found that cardiovascular disease is a significant public health concern in the region, with high rates of risk factors such as hypertension and diabetes.
Dr. Roxana Mehran is recognized for her exceptional contributions to cardiovascular medicine, including designing and implementing randomized clinical trials and outcomes research projects. She has also focused on personalized medicine and developed individual risk scores for bleeding and acute kidney injury.
A study found that physiology-guided complete revascularization in older patients (75 years+) with myocardial infarction and multivessel disease provides sustained benefit at 3 years compared to culprit-lesion-only treatment. This approach may improve outcomes for elderly patients with complex coronary artery disease.
A remote randomized clinical trial found that mail-based atrial fibrillation screening with an electrocardiogram patch increased AF diagnosis in older patients at moderate to high risk of stroke over 2.5 years. The study suggests that this method could be a potential strategy for stroke prevention.
A simulation study suggests that deploying food delivery riders to deliver defibrillation can reduce automated external defibrillator response times by approximately three minutes, reducing patient waiting time for defibrillation. The approach offers a cost-effective and scalable strategy for improving cardiac arrest outcomes in high-d...
Barbara Casadei has been appointed as the next Editor in Chief of JAMA Cardiology, bringing her expertise in cardiovascular research to the role. She aims to broaden the journal's global impact and drive the evolution of cardiology.
A case series of 19 patients has successfully undergone partial heart transplant, enabling valve growth and representing a novel approach to congenital heart disease treatment. Careful follow-up and monitoring are crucial for the continued expansion of this procedure.
The American College of Cardiology recommends flu, COVID-19, RSV vaccinations and others for adults with heart disease to reduce risks of infection, hospitalization, and death. Vaccination has been shown to be highly effective in reducing these risks, yet only 30% of primary care physicians assess patients' vaccination status.
Researchers found a connection between high TMAO levels and faster rates of aneurysm expansion, as well as greater risk for needing surgery. Targeting TMAO levels may help prevent and treat aneurysmal disease beyond surgery.
The Society for Cardiovascular Angiography & Interventions (SCAI) has published a new position statement providing best-practice guidance for the treatment of patent ductus arteriosus (PDA) in premature infants using transcatheter occlusion. The guidance emphasizes patient selection, pre-procedural planning, and post-procedure follow-u...
NewYork-Presbyterian/Weill Cornell Medical Center has been recognized as a mitral valve repair reference center by the Mitral Foundation for three consecutive years. The award highlights the institution's commitment to delivering high-quality care and advancing best practices in surgical treatment of mitral valve disease.
A study led by Lancaster University found that social and environmental factors impact a patient's physical readiness for surgery. Patients from socioeconomically deprived areas tend to have lower cardiorespiratory fitness, which can lead to poorer surgical outcomes.
The American Heart Association (AHA) and the American College of Cardiology (ACC) have published a new set of clinical practice guidelines for left atrial appendage occlusion (LAAO) to guide stroke prevention in non-valvular atrial fibrillation (NVAF) patients. The guidelines provide specific recommendations for clinicians, patients, a...
A study of 1,081 elderly patients with AFMR found that TEER minimally invasive valve repair significantly lowered mortality and hospitalization rates compared to standard medical therapy alone. The procedure's success was also linked to the degree of residual mitral regurgitation after surgery.
A study in the Canadian Journal of Cardiology finds that delaying chest compressions to prevent tongue swallowing can lead to poor outcomes, including death or severe brain injury. The research exposes media-fueled misconceptions and emphasizes the importance of immediate CPR training.
A new online tool calculates a person's 'heart age' based on cardiovascular disease risk factors, revealing significant gaps among certain groups. On average, women had a heart age of 55.4, while men had an average heart age of 56.7, with disparities found among those with lower incomes or education.
A coordinated approach is needed to address the scientific value of trial representation of the intended use population. The study aims to provide a strategic framework to ensure scientific validity by operationalizing broad representation at all levels.
At ESC Congress 2025, over 40 pivotal studies will be presented, addressing major clinical questions and unmet needs in global cardiovascular care. The trials focus on innovative treatments for conditions like chronic Chagas cardiomyopathy and hypertrophic cardiomyopathy.
The Mount Sinai Hospital has been listed among the nation's top 20 hospitals for care excellence by U.S. News & World Report for 2025-26, with top-10 rankings in five specialties and top-20 rankings in nine. The hospital was also rated High Performing in all 22 procedures and conditions assessed by U.S. News.
Researchers from FAU's Schmidt College of Medicine recommend using high-potency statins as the primary pharmacologic approach in treating and preventing cardiovascular disease. Lifestyle changes, such as regular physical activity and a healthy diet, are also crucial in reducing cardiovascular risk.
The 250,000-square-foot facility provides greater availability to high-quality integrated care, addressing the region's increasing demand for innovative diagnostic and treatment services. The pavilion brings together a broad range of nationally ranked clinical programs, including cancer clinics, neurology, and surgery.
A large clinical study found that high-tech oxygen level monitoring during heart surgery did not lower the risk of serious complications afterward. Fewer pneumonia cases were reported in patients with advanced monitoring, but this difference may have been coincidental.
This study found that moderate to vigorous-intensity physical activity declined from early adulthood to midlife, with notable demographic differences. Black women experienced the lowest physical activity across adulthood and highest risk of low physical activity post-CVD.
Research warns that GLP-1 drugs may not provide the long-term health benefit of improved heart and lung function. While they help with weight loss, patients may experience significant muscle loss, which can increase cardiovascular disease risk. Doctors are urging additional research to better understand the effects of these drugs.
Delays in hypertension diagnosis were common, associated with delayed treatment initiation and adverse cardiovascular outcomes. The study highlights the need for earlier identification and intervention to improve treatment and patient outcomes.
A study of over 7,600 Brazilian women found that early menarche increases risk for metabolic and heart problems, while late menarche may protect against obesity but increase certain heart issues. Understanding age at first period can help doctors identify high-risk patients and guide personalized screening and prevention efforts.
Researchers developed a new diagnostic method using Doppler ultrasound waveform to estimate toe brachial index (TBI), providing faster and more accurate results for early detection of peripheral artery disease (PAD). The study found eTBI to be consistent with standard TBI, detecting effectiveness of treatments in improving blood flow.
Researchers developed an AI model that screens for cardiac amyloidosis with high accuracy, outperforming existing methods. The tool analyzes routine heart ultrasound images to quickly detect the condition and differentiate it from other heart issues.
Researchers highlight a significant gap in detecting symptoms and preventive measures before myocardial infarctions, with distinct differences found between age groups and genders.
The Society for Cardiovascular Angiography and Interventions (SCAI) has published evidence-based clinical practice guidelines for the management of chronic venous disease. The guidelines provide patient-centered recommendations on therapeutic options, including compression therapy, wound care, and minimally invasive procedures. Key fin...
Researchers at University of Liège developed a safer, more environmentally friendly polymer called PHOx, which outperforms traditional polyurethane in critical medical applications. PHOx reduces blood clotting risks, inhibits bacterial adhesion, and is biocompatible, making it suitable for custom-made implants.
A new ESC Clinical Consensus Statement highlights vaccination as a crucial preventive strategy for reducing cardiovascular events following viral and bacterial infections. Vaccines are recommended for patients with chronic coronary syndromes and heart failure, particularly those at increased risk due to underlying medical conditions.
Academic medical centers can transform patient care by adopting learning health system principles, harnessing real-time data analysis and AI to improve patient outcomes. The proposed model aims to establish a smarter, more efficient and equitable care model by integrating diverse databases and leveraging AI for personalized, proactive ...
A decrease in acute myocardial infarction deaths has led to an increase in deaths from other types of chronic heart conditions. The researchers attribute this shift to improved management and prevention of heart attacks, resulting in more patients living beyond these events and developing other heart conditions.
A study published in JACC found that long-term exposure to wildfire smoke may increase the risk of heart failure, particularly among older adults, women, and those living in lower-income areas. The risk was found to be higher with increased levels of PM2.5 air pollution from wildfires compared to other types of air pollution.
Cancer patients treated with immune checkpoint inhibitors are at risk of heart damage due to rapid loss of protective immune cells. Researchers found a biomarker, CD69, can predict which patients are most at risk and may help doctors monitor them more closely.
A study found that specific bacteria in breast cancer patients' gut microbiomes correlate with heart health biomarkers, suggesting they are at greater risk of heart damage during chemotherapy. Researchers hope tailored probiotics could play a role in protecting patients against the harmful effects of cancer treatment.
JMIR Publications' portfolio of journals now includes 21 titles with a Journal Impact Factor. Several journals saw significant increases in impact factor, including JMIR Medical Education, which debuted with a score of 12.5, securing the top-ranked journal spot in its category.
The BMJ finds serious misreporting in two key platelet studies used to gain FDA approval for ticagrelor, a multibillion-dollar heart drug. The investigation reveals inaccurate primary endpoint results and unreported data, casting fresh doubts on the drug's safety and effectiveness.
The collaboration aims to co-develop new treatment paradigms and accelerate innovation in cardiac care, with a focus on Asian populations. The partnership will create opportunities for breakthrough research, knowledge exchange, and training for healthcare professionals.
The Journal EuroIntervention has recorded an impressive Impact Factor of 9.5, making it one of the most cited publications in interventional cardiology. This achievement is attributed to the journal's commitment to publishing high-quality clinical articles and expert commentaries.
PerDeCT is a device designed to monitor cardiac patients after surgery and provide early diagnosis of cardiac tamponade. The device aims to balance the benefit and risk of using devices to monitor cardiac output and detect tamponade easily, before damage is done.
The new program offers minimally invasive treatments for cardiovascular issues, including transcatheter aortic valve replacement and left atrial appendage occlusion. The cardiac catheterization lab features state-of-the-art equipment, allowing improved diagnostic imaging and safer procedures.
Researchers at Stanford Medicine successfully grew heart and liver organoids with integrated blood vessels, allowing them to overcome the current size limit. These vascularized organoids can grow larger and reach a more mature state, making them more useful as biological models for research and potential treatment of various diseases.
The ACC Care of the Athletic Heart conference equips cardiovascular care teams with tools to succeed in sports cardiology. The event covers core sports cardiology tools and case-based learning for competitive and tactical athletes.
A novel screening approach called VEST uses virtual echocardiography to identify patients at high risk of pulmonary arterial hypertension, a life-threatening form of heart failure. The tool has been shown to generate accurate PAH risk scores without manual calculations and can guide timely referrals for expert care.
The Association of Cardiovascular Nursing and Allied Professions (ACNAP) will host its annual congress from 12 to 14 June 2025 in Sophia Antipolis, France. Nurses and allied health professionals will share knowledge and network to drive real change in cardiovascular care.
A recent study found that nearly 1 in 6 adults with hypertension and 3 in 10 with diabetes were unaware of their condition by 2021-2023. Young adults and women are disproportionately affected by a lack of awareness.
A cohort study of schools found that COVID-19-related decline in youth physical fitness persisted during the pandemic, but not associated with remote or hybrid environments. The reduction was observed in cardiorespiratory and musculoskeletal fitness healthy zone achievement.
A new study reveals that combining heart valve replacement with specific drug therapy offers significant survival benefits for patients with severe aortic stenosis and cardiac amyloidosis. The treatment significantly lowers the risk of death in both forms of treatment, especially when combined.